125 related articles for article (PubMed ID: 23281057)
21. Serum 25-hydroxyvitamin D
Young LR; Backus RC
J Nutr Sci; 2017; 6():e30. PubMed ID: 29152235
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D status and concentrations of serum vitamin D metabolites and osteocalcin in elderly patients with femoral neck fracture: a follow-up study.
Lamberg-Allardt C; von Knorring J; Slätis P; Holmström T
Eur J Clin Nutr; 1989 May; 43(5):355-61. PubMed ID: 2786805
[TBL] [Abstract][Full Text] [Related]
24. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels.
Bikle DD; Siiteri PK; Ryzen E; Haddad JG
J Clin Endocrinol Metab; 1985 Nov; 61(5):969-75. PubMed ID: 3840175
[TBL] [Abstract][Full Text] [Related]
25. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
Jean G; Souberbielle JC; Chazot C
Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
[TBL] [Abstract][Full Text] [Related]
26. Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites.
Ittel TH; Hofstädter F; Gladziwa U; Sieberth HG
Nephrol Dial Transplant; 1989; 4(11):957-65. PubMed ID: 2516887
[TBL] [Abstract][Full Text] [Related]
27. Peculiarities of vitamin D and of the calcium and phosphate homeostatic system in horses.
Breidenbach A; Schlumbohm C; Harmeyer J
Vet Res; 1998; 29(2):173-86. PubMed ID: 9601149
[TBL] [Abstract][Full Text] [Related]
28. Antagonistic effects of 24R,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 on L-type Ca2+ channels and Na+/Ca2+ exchange in enterocytes from Atlantic cod (Gadus morhua).
Larsson D; Larsson D; Aksnes L; Th Björnsson B; Larsson B; Larsson B; Lundgren T; Sundell K
J Mol Endocrinol; 2002 Feb; 28(1):53-68. PubMed ID: 11854099
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.
Ishimura E; Nishizawa Y; Inaba M; Matsumoto N; Emoto M; Kawagishi T; Shoji S; Okuno S; Kim M; Miki T; Morii H
Kidney Int; 1999 Mar; 55(3):1019-27. PubMed ID: 10027939
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity.
Pettifor JM; Bikle DD; Cavaleros M; Zachen D; Kamdar MC; Ross FP
Ann Intern Med; 1995 Apr; 122(7):511-3. PubMed ID: 7872586
[TBL] [Abstract][Full Text] [Related]
31. Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing.
Vaculik J; Wenchich L; Bobelyak M; Pavelka K; Stepan JJ
J Endocrinol Invest; 2021 Sep; 44(9):1847-1855. PubMed ID: 33492601
[TBL] [Abstract][Full Text] [Related]
32. Putative basal lateral membrane receptors for 24,25-dihydroxyvitamin D(3) in carp and Atlantic cod enterocytes: characterization of binding and effects on intracellular calcium regulation.
Larsson D; Nemere I; Sundell K
J Cell Biochem; 2001 Aug 1-9; 83(2):171-86. PubMed ID: 11573235
[TBL] [Abstract][Full Text] [Related]
33. Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2.
Martineau C; Naja RP; Husseini A; Hamade B; Kaufmann M; Akhouayri O; Arabian A; Jones G; St-Arnaud R
J Clin Invest; 2018 Aug; 128(8):3546-3557. PubMed ID: 30010626
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D, vitamin D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patients.
Subramanian S; Rhodes JM; Taylor JM; Milan AM; Lane S; Hewison M; Chun RF; Jorgensen A; Richardson P; Nitchingham D; Aslan J; Shah M; Chandrasekar CR; Wood A; Beadsworth M; Pirmohamed M
Am J Clin Nutr; 2022 May; 115(5):1367-1377. PubMed ID: 35102371
[TBL] [Abstract][Full Text] [Related]
35. Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding.
van Hoof HJ; de Sévaux RG; van Baelen H; Swinkels LM; Klipping C; Ross HA; Sweep CG
Eur J Endocrinol; 2001 Apr; 144(4):391-6. PubMed ID: 11275949
[TBL] [Abstract][Full Text] [Related]
36. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein.
Falch JA; Oftebro H; Haug E
J Clin Endocrinol Metab; 1987 Apr; 64(4):836-41. PubMed ID: 3818905
[TBL] [Abstract][Full Text] [Related]
37. Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites.
Jones KS; Redmond J; Fulford AJ; Jarjou L; Zhou B; Prentice A; Schoenmakers I
J Steroid Biochem Mol Biol; 2017 Sep; 172():130-135. PubMed ID: 28732681
[TBL] [Abstract][Full Text] [Related]
38. Blood levels of active metabolites of vitamin D3 in fracture repair in humans. A preliminary report.
Tauber C; Noff D; Noff M; Malkin C
Arch Orthop Trauma Surg; 1990; 109(5):265-7. PubMed ID: 2271359
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
Yang L; Chen H; Zhao M; Peng P
Oncotarget; 2017 Jun; 8(25):40214-40221. PubMed ID: 28388568
[TBL] [Abstract][Full Text] [Related]
40. 24,25-Dihydroxyvitamin D(3) and bone metabolism.
van Leeuwen JP; van den Bemd GJ; van Driel M; Buurman CJ; Pols HA
Steroids; 2001; 66(3-5):375-80. PubMed ID: 11179746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]